An open-label phase I dose escalation study of intravenous infusion of tetra-o-methyl nordihydroguaiaretic acid (EM-1421) in subjects with refractory malignant tumors.
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Terameprocol (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Erimos Pharmaceuticals
- 23 Jan 2008 The expected completion date for this trial is now 1 Jan 2008.
- 23 Jan 2008 Status changed from recruiting to completed.
- 25 Dec 2005 New trial record.